Vimarsana
Biggest News Aggregation in the World

Page 29 - Study Author News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Study Author. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Study Author Today - Breaking & Trending Today

A New Sustainable Plastic Upcycling Process - Vimarsana News

A New Sustainable Plastic Upcycling Process

Grocery bags, used face masks, and food wraps potentially contain plenty of useful raw materials in them. But it has been much more economical to keep manufacturing more of these one-time-use plastics than to undertake recovery and recycling processes of those items.

Nanofluidic Devices to Study of Single Molecule Chemical Reactions - Vimarsana News

Nanofluidic Devices to Study of Single Molecule Chemical Reactions

As molecules from various substances interact to generate new molecules, the bonds between their atoms are altered. This is known as a chemical reaction.

Source: azom.com
Using Self-Assembling Nanoparticles in Solar Energy Harvesting - Vimarsana News

Using Self-Assembling Nanoparticles in Solar Energy Harvesting

A promising eco-friendly energy harvesting method called solar-thermal technology has a crucial role to play in resolving the crisis of fossil fuel energy.

Structure of DREADD designer receptor could pave the way for creating next generation tools - Vimarsana News

Structure of DREADD designer receptor could pave the way for creating next generation tools

In order to more fully understand how diseases arise in the brain, scientists must unravel the intricate way neurons relay messages (either chemical or electrical) along a complex web of nerve cells.

Ethnic and regional minorities derive at least as much cardiovascular benefit from lipid-lowering therapies - Vimarsana News

Ethnic and regional minorities derive at least as much cardiovascular benefit from lipid-lowering therapies

Minority ethnicities and regions derive at least as much cardiovascular benefit from lipid-lowering therapies as majority groups despite being underrepresented in clinical trials, according to a study published today in the European Journal of Preventive Cardiology, a journal of the ESC.